sibo and glp 1 treatment methods sibo and glp 1 New

The FDA Shortage List: A Double-Edged Sword High demand has pushed GLP-1 drugs like semaglutide and tirzepatide onto the FDAs drug shortage list, greenlighting compounding pharmacies to produce versions of these drugs

Remember that preventing nutritional deficiencies is much easier than treating them after they occur

Periods of reduced physical activity due to fatigue or restrictive diets during rapid weight loss can lead to prolonged immobility, increasing the risk of venous stasis and clot formation

Patients experiencing denials can request expedited reviews if documentation demonstrates acute medical necessity, potentially reducing decision timelines to 24-48 hours

DOI: 10.1016/j.molmet.2021.101206